Team reports validation of potentially powerful new way to treat HER2-positive breast cancer

Scientists at Cold Spring Harbor Laboratory (CSHL) today report a discovery that they hope will lead to the development of a powerful new way of treating an aggressive form of breast cancer.
The breast cancer subtype in question is commonly called ‘HER2-positive’; it